Cargando…

CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy

BACKGROUND: The clinical value of left ventricular (LV) global longitudinal strain (GLS) in the differential diagnosis of light-chain cardiac amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) has been previously reported. In this study, we analyzed the potential clinical value of the LV long...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fangqing, Deng, Yan, Li, Shunjia, Cheng, Qichao, Wang, Qing, Yu, Dexin, Wang, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188937/
https://www.ncbi.nlm.nih.gov/pubmed/37206101
http://dx.doi.org/10.3389/fcvm.2023.1108408
_version_ 1785042972327280640
author Wang, Fangqing
Deng, Yan
Li, Shunjia
Cheng, Qichao
Wang, Qing
Yu, Dexin
Wang, Qian
author_facet Wang, Fangqing
Deng, Yan
Li, Shunjia
Cheng, Qichao
Wang, Qing
Yu, Dexin
Wang, Qian
author_sort Wang, Fangqing
collection PubMed
description BACKGROUND: The clinical value of left ventricular (LV) global longitudinal strain (GLS) in the differential diagnosis of light-chain cardiac amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) has been previously reported. In this study, we analyzed the potential clinical value of the LV long-axis strain (LAS) to discriminate AL-CA from HCM. Furthermore, we analyzed the association between all the LV global strain parameters derived from cardiac magnetic resonance (CMR) feature tracking and LAS in both the AL-CA and HCM patients to assess the differential diagnostic efficacies of these global peak systolic strains. MATERIALS AND METHODS: Thus, this study enrolled 89 participants who underwent cardiac MRI (CMRI), consisting of 30 AL-CA patients, 30 HCM patients, and 29 healthy controls. The intra- and inter-observer reproducibility of the LV strain parameters including GLS, global circumferential strain (GCS), global radial strain (GRS), and LAS were assessed in all the groups and compared. Receiver operating characteristic (ROC) curve analysis was performed to determine the diagnostic performances of the CMR strain parameters in discriminating AL-CA from HCM. RESULTS: The intra- and inter-observer reproducibility of the LV global strains and LAS were excellent (range of interclass correlation coefficients: 0.907–0.965). ROC curve analyses showed that the differential diagnostic performances of the global strains in discriminating AL-CA from HCM were good to excellent (GRS, AUC = 0.921; GCS, AUC = 0.914; GLS, AUC = 0.832). Furthermore, among all the strain parameters analyzed, LAS showed the highest diagnostic efficacy in differentiating between AL-CA and HCM (AUC = 0.962). CONCLUSION: CMRI-derived strain parameters such as GLS, LAS, GRS, and GCS are promising diagnostic indicators that distinguish AL-CA from HCM with high accuracy. LAS showed the highest diagnostic accuracy among all the strain parameters.
format Online
Article
Text
id pubmed-10188937
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101889372023-05-18 CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy Wang, Fangqing Deng, Yan Li, Shunjia Cheng, Qichao Wang, Qing Yu, Dexin Wang, Qian Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: The clinical value of left ventricular (LV) global longitudinal strain (GLS) in the differential diagnosis of light-chain cardiac amyloidosis (AL-CA) and hypertrophic cardiomyopathy (HCM) has been previously reported. In this study, we analyzed the potential clinical value of the LV long-axis strain (LAS) to discriminate AL-CA from HCM. Furthermore, we analyzed the association between all the LV global strain parameters derived from cardiac magnetic resonance (CMR) feature tracking and LAS in both the AL-CA and HCM patients to assess the differential diagnostic efficacies of these global peak systolic strains. MATERIALS AND METHODS: Thus, this study enrolled 89 participants who underwent cardiac MRI (CMRI), consisting of 30 AL-CA patients, 30 HCM patients, and 29 healthy controls. The intra- and inter-observer reproducibility of the LV strain parameters including GLS, global circumferential strain (GCS), global radial strain (GRS), and LAS were assessed in all the groups and compared. Receiver operating characteristic (ROC) curve analysis was performed to determine the diagnostic performances of the CMR strain parameters in discriminating AL-CA from HCM. RESULTS: The intra- and inter-observer reproducibility of the LV global strains and LAS were excellent (range of interclass correlation coefficients: 0.907–0.965). ROC curve analyses showed that the differential diagnostic performances of the global strains in discriminating AL-CA from HCM were good to excellent (GRS, AUC = 0.921; GCS, AUC = 0.914; GLS, AUC = 0.832). Furthermore, among all the strain parameters analyzed, LAS showed the highest diagnostic efficacy in differentiating between AL-CA and HCM (AUC = 0.962). CONCLUSION: CMRI-derived strain parameters such as GLS, LAS, GRS, and GCS are promising diagnostic indicators that distinguish AL-CA from HCM with high accuracy. LAS showed the highest diagnostic accuracy among all the strain parameters. Frontiers Media S.A. 2023-05-03 /pmc/articles/PMC10188937/ /pubmed/37206101 http://dx.doi.org/10.3389/fcvm.2023.1108408 Text en © 2023 Wang, Deng, Li, Cheng, Wang, Yu and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wang, Fangqing
Deng, Yan
Li, Shunjia
Cheng, Qichao
Wang, Qing
Yu, Dexin
Wang, Qian
CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
title CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
title_full CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
title_fullStr CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
title_full_unstemmed CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
title_short CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
title_sort cmr left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188937/
https://www.ncbi.nlm.nih.gov/pubmed/37206101
http://dx.doi.org/10.3389/fcvm.2023.1108408
work_keys_str_mv AT wangfangqing cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy
AT dengyan cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy
AT lishunjia cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy
AT chengqichao cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy
AT wangqing cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy
AT yudexin cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy
AT wangqian cmrleftventricularstrainsbeyondgloballongitudinalstrainindifferentiatinglightchaincardiacamyloidosisfromhypertrophiccardiomyopathy